Ron Bentsur - 14 May 2024 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
14 May 2024
Net transactions value
+$13,076
Form type
4
Filing time
15 May 2024, 09:16:46 UTC
Previous filing
13 May 2024
Next filing
18 Nov 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $13,076 +1,940 +0.06% $6.74 3,246,424 14 May 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average purchase price. The range of prices for the shares purchased was $6.65 to $6.94. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price
F2 Includes 426,759 shares of restricted stock.